Adaptive Biotechnologies Corp balance sheet

At the end of fiscal 2025, Adaptive Biotechnologies Corp had total assets of $513m, total liabilities of $288m and shareholders' equity of $219m. It held $70.5m in cash against $131m of debt: net debt of $60.7m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Adaptive Biotechnologies Corp: balance sheet, annual
Fiscal year	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	—	55	97	123	139	90	65	48	70	170
Receivables	—	5	13	10	17	40	38	42	50	50
Inventory	—	8	9	14	19	14	14	8	10	10
Total current assets	—	181	613	727	403	562	410	284	300	421
Goodwill	—	119	119	119	119	119	119	119	119	119
Total assets	—	333	912	1,116	923	857	661	539	513	641
Accounts payable	—	2	4	3	3	8	8	7	6	5
Deferred revenue (current)	—	13	61	73	80	64	49	56	45	53
Total current liabilities	—	23	78	105	114	110	88	98	90	88
Short-term debt	—	—	—	—	—	—	—	1	5	0
Long-term debt	—	—	—	—	—	125	131	132	127	0
Total debt	—	0	0	0	0	125	131	133	131	0
Total liabilities	—	30	341	373	319	393	353	337	288	490
Shareholders' equity	−225	−258	571	743	604	464	308	203	219	143
Non-controlling interests and other (assets − liabilities − equity)	—	561	—	—	—	—	—	—	—	—
Net debt (negative = net cash)	—	−55	−97	−123	−139	35	66	85	61	−170
Shares outstanding	—	26m	125m	138m	141m	143m	145m	148m	154m	159m

US$ millions unless shown otherwise. Fiscal quarters.

Adaptive Biotechnologies Corp: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	41	42	44	44	45	50	48	50
Inventory	12	8	9	8	10	10	11	10
Total current assets	308	284	256	262	281	300	292	421
Goodwill	119	119	119	119	119	119	119	119
Total assets	559	539	511	497	491	513	506	641
Accounts payable	7	7	6	7	10	6	10	5
Deferred revenue (current)	52	56	55	55	41	45	49	53
Total current liabilities	88	98	88	92	83	90	87	88
Short-term debt	—	1	2	3	2	5	6	0
Long-term debt	133	132	132	130	129	127	125	0
Total debt	133	133	134	134	132	131	131	0
Total liabilities	335	337	321	317	286	288	282	490
Shareholders' equity	224	203	190	180	204	219	216	143
Shares outstanding	148m	148m	152m	152m	153m	154m	160m	159m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ADPT vs VCEL ADPT vs VIR ADPT vs ARVN ADPT vs IOVA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Adaptive Biotechnologies Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Adaptive Biotechnologies Corp.